As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like ...

Oikos and its other popular brands are seeing a spike in demand as people taking the weight-loss medications turn to the portion-controlled snacks to meet their nutritional needs.

One in eight people living in the United States has taken a GLP-1 medication — such as Ozempic, Mounjaro, or Zepbound — for ...

The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs Ozempic, Wegovy and Rybelsus, for the ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

There are a range of such drugs on the market, under a number of different brand names. Many of them have only been approved for sale in the last few years. The most widely known of GLP-1 drugs, ...

Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Direct-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1 weight loss drugs for a ...

Last month, Nestlé launched a pre-meal drink under its Boost brand aimed at GLP-1 drug users in the US. The Swiss giant is also selling a range of meals in the US designed as a “companion ...